The abstract is read at the publisher; the summary is JClub's.
Palmitic acid exposure in cardiomyocytes promotes a pro-hypertrophic memory linked to KDM5A/H3K4me3, driving cardiac hypertrophy and heart failure in mice.
- Why it matters: High saturated fatty acids are associated with heart failure risk, but how palmitic acid produces lasting cardiac remodeling and which targets mediate it are unclear.
- What they did: The study combined a UK Biobank analysis of 232 592 participants with mouse diet experiments (4 weeks PA-enriched, then 4 weeks control) plus transverse aortic constriction and Kdm5A knockout models. It also used in vitro/in vivo mechanistic tests showing PA triggers palmitoylation-driven KDM5A degradation, increasing H3K4me3 and MCT4-linked metabolic imbalance.
- The result: PA treatment promoted hypertrophy and heart failure even after returning to control diet, and the KDM5A agonist D18 ameliorated PA-mediated cardiac hypertrophy and HF.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.